XML 16 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues        
Revenues $ 117,085 $ 86,742 $ 319,178 $ 238,011
Expenses:        
Cost of product sales 3,211 1,099 6,175 2,924
Research and development 41,081 46,879 125,197 146,514
Selling, general and administrative 65,084 50,648 185,662 149,512
Royalty 17 37 179 100
Total operating expenses 109,393 98,663 317,213 299,050
Income (loss) from operations 7,692 (11,921) 1,965 (61,039)
Interest income 3,591 4,184 11,176 11,312
Interest expense (24,828) (27,345) (74,067) (83,656)
Foreign currency gains (losses), net 98 (737) (37) (665)
Loss on extinguishment of debt 0 0 0 (29,019)
Loss before income taxes (13,447) (35,819) (60,963) (163,067)
Income tax expense 586 330 1,123 1,741
Net loss (14,033) (36,149) (62,086) (164,808)
Foreign currency translation adjustment 563 (185) 170 (67)
Unrealized gain on available for sale investments 1,173 295 786 841
Net comprehensive loss $ (12,297) $ (36,039) $ (61,130) $ (164,034)
Basic net loss per common share (in usd per share) $ (0.07) $ (0.19) $ (0.30) $ (0.87)
Diluted net loss per common share (in usd per share) $ (0.07) $ (0.19) $ (0.30) $ (0.87)
Weighted average shares outstanding, basic (in shares) 206,905 189,644 206,466 189,095
Weighted average shares outstanding, diluted (in shares) 206,905 189,644 206,466 189,095